1.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 to 70 Sponsor: Other Protocol IDs: ECF/endo-MGC, NCT00595972
|
|
2.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 to 70 Sponsor: Other Protocol IDs: Endostar B-01, XOBCR01, NCT00604435
|
|
3.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 to 75 Sponsor: Pharmaceutical / Industry Protocol IDs: XYL014, NCT00708812
|
|
4.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 to 75 Sponsor: Pharmaceutical / Industry Protocol IDs: SIM-69, NCT00912392
|
|
5.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 to 70 Sponsor: Other Protocol IDs: DP-EN-RT, NCT01218594
|
|
6.
|
Phase: Phase II Type: Diagnostic, Treatment Status: Closed Age: 18 to 70 Sponsor: Other Protocol IDs: XIANSHENG, NCT01347424
|
|
7.
|
Phase: Phase I Type: Treatment Status: Completed Age: Over 18 Sponsor: NCI, Other Protocol IDs: CDR0000067532, P30CA014520, WCCC-CO-99910, NCI-T99-0055, T99-0055, NCT00004872
|
|
8.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 to 70 Sponsor: Pharmaceutical / Industry Protocol IDs: SIM-93, NCT01531790
|